Home LiteratureArticle Details
PMID: 17438126 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

Molecular and cellular biology ·Vol. 27 ·No. 12 ·2007-06-00 ·Pages 4374-87

Wang H, Hertlein E, Bakkar N, Sun H, Acharyya S, Wang J, Carathers M, Davuluri R, Guttridge DC

Abstract

NF-kappaB signaling is implicated as an important regulator of skeletal muscle homeostasis, but the mechanisms by which this transcription factor contributes to muscle maturation and turnover remain unclear. To gain insight into these mechanisms, gene expression profiling was examined in C2C12 myoblasts devoid of NF-kappaB activity. Interestingly, even in proliferating myoblasts, the absence of NF-kappaB caused the pronounced induction of several myofibrillar genes, suggesting that NF-kappaB functions as a negative regulator of late-stage muscle differentiation. Although several myofibrillar promoters contain predicted NF-kappaB binding sites, functional analysis using the troponin-I2 gene as a model revealed that NF-kappaB-mediated repression does not occur through direct DNA binding. In the search for an indirect mediator, the transcriptional repressor YinYang1 (YY1) was identified. While inducers of NF-kappaB stimulated YY1 expression in multiple cell types, genetic ablation of the RelA/p65 subunit of NF-kappaB in both cultured cells and adult skeletal muscle correlated with reduced YY1 transcripts and protein. NF-kappaB regulation of YY1 occurred at the transcriptional level, mediated by direct binding of the p50/p65 heterodimer complex to the YY1 promoter. Furthermore, YY1 was found associated with multiple myofibrillar promoters in C2C12 myoblasts containing NF-kappaB activity. Based on these results, we propose that NF-kappaB regulation of YY1 and transcriptional silencing of myofibrillar genes represent a new mechanism by which NF-kappaB functions in myoblasts to modulate skeletal muscle differentiation.

MeSH Terms
Animals Cell Culture Techniques Cell Differentiation Cell Line Cell Line, Tumor Cells, Cultured Chromatin Immunoprecipitation Gene Expression Profiling Gene Expression Regulation, Developmental Gene Silencing Genes, Reporter Humans Immunohistochemistry Luciferases/metabolism Mice Models, Biological Muscle Development/physiology Myoblasts/cytology,metabolism Myofibrils/genetics NF-kappa B/genetics,metabolism Plasmids Transfection YY1 Transcription Factor/genetics,metabolism
Chemicals
NF-kappa B YY1 Transcription Factor Yy1 protein, mouse Luciferases
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Wang Huating
Human Cancer Genetics Program, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
Hertlein Erin
Bakkar Nadine
Sun Hao
Acharyya Swarnali
Wang Jingxin
Carathers Micheal
Davuluri Ramana
Guttridge Denis C
References (65)
65 references, click to expand
  1. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6.
    Mol Biol Cell. 2004 Apr;15(4):2013-26 PMID: 14767066
  2. Signaling to NF-kappaB.
    Genes Dev. 2004 Sep 15;18(18):2195-224 PMID: 15371334
  3. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
    Cell. 2004 Oct 15;119(2):285-98 PMID: 15479644
  4. Expanded nuclear roles for IkappaBs.
    Sci STKE. 2004 Oct 12;2004(254):pe48 PMID: 15479861
  5. Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts.
    Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9814-8 PMID: 1409704
  6. Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle.
    Mol Cell Biol. 1993 Feb;13(2):1264-72 PMID: 8423791
  7. Characterization of the mouse gene that encodes the delta/YY1/NF-E1/UCRBP transcription factor.
    Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5559-63 PMID: 8516301
  8. Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6145-9 PMID: 8327494
  9. Regulation of the human cardiac/slow-twitch troponin C gene by multiple, cooperative, cell-type-specific, and MyoD-responsive elements.
    Mol Cell Biol. 1993 Nov;13(11):6752-65 PMID: 8413270
  10. Interaction between transcription factors Sp1 and YY1.
    Nature. 1993 Sep 30;365(6445):462-4 PMID: 8003102
  11. Characterization of cis-regulating elements and trans-activating factors of the rat cardiac troponin T gene.
    J Biol Chem. 1994 Dec 2;269(48):30595-603 PMID: 7982978
  12. Structure, regulation and function of NF-kappa B.
    Annu Rev Cell Biol. 1994;10:405-55 PMID: 7888182
  13. Rel/NF-kappa B/I kappa B story.
    Adv Cancer Res. 1995;66:255-92 PMID: 7793317
  14. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
    Nature. 1995 Jul 13;376(6536):167-70 PMID: 7603567
  15. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Genes Dev. 1995 Nov 15;9(22):2723-35 PMID: 7590248
  16. DNA binding sites for the transcriptional activator/repressor YY1.
    Nucleic Acids Res. 1995 Nov 11;23(21):4457-65 PMID: 7501470
  17. The NF-kappa B and I kappa B proteins: new discoveries and insights.
    Annu Rev Immunol. 1996;14:649-83 PMID: 8717528
  18. Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes.
    J Biol Chem. 1996 Aug 30;271(35):21134-41 PMID: 8702883
  19. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.
    Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12845-50 PMID: 8917507
  20. Down-regulation of transcription factors AP-1, Sp-1, and NF-kappa B precedes myocyte differentiation.
    Biochem Biophys Res Commun. 1996 Dec 4;229(1):36-43 PMID: 8954080
  21. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.
    Mol Cell. 2004 Mar 26;13(6):853-65 PMID: 15053878
  22. Structural characterization of the human fast skeletal muscle troponin I gene (TNNI2).
    Gene. 2000 Jan 25;242(1-2):313-20 PMID: 10721725
  23. Signaling pathways weigh in on decisions to make or break skeletal muscle.
    Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):443-50 PMID: 15192448
  24. Yin Yang 1 is a negative regulator of p53.
    Cell. 2004 Jun 25;117(7):859-72 PMID: 15210108
  25. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
    J Clin Invest. 2004 Aug;114(3):370-8 PMID: 15286803
  26. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers.
    Cell. 2004 Aug 20;118(4):453-64 PMID: 15315758
  27. The molecular basis of skeletal muscle atrophy.
    Am J Physiol Cell Physiol. 2004 Oct;287(4):C834-43 PMID: 15355854
  28. The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression.
    Mol Cell Biol. 2004 Oct;24(19):8705-15 PMID: 15367688
  29. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein.
    J Biol Chem. 1997 Jan 17;272(3):1709-17 PMID: 8999850
  30. NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses.
    J Exp Med. 1997 Mar 3;185(5):953-61 PMID: 9120401
  31. Multiple mechanisms of transcriptional repression by YY1.
    Mol Cell Biol. 1997 Jul;17(7):3723-32 PMID: 9199306
  32. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.
    Cell. 1997 Oct 17;91(2):243-52 PMID: 9346241
  33. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
    Annu Rev Immunol. 1998;16:225-60 PMID: 9597130
  34. A 3'-flanking NF-kappaB site mediates developmental silencing of the human zeta-globin gene.
    EMBO J. 1999 Apr 15;18(8):2218-28 PMID: 10205175
  35. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway.
    J Biol Chem. 1999 Jun 18;274(25):17437-44 PMID: 10364173
  36. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
    Mol Cell Biol. 1999 Aug;19(8):5785-99 PMID: 10409765
  37. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?
    Gene. 1999 Aug 20;236(2):197-208 PMID: 10452940
  38. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
    Genes Dev. 2004 Nov 1;18(21):2627-38 PMID: 15520282
  39. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy.
    J Clin Invest. 2004 Nov;114(10):1504-11 PMID: 15546001
  40. RelA/p65 regulation of IkappaBbeta.
    Mol Cell Biol. 2005 Jun;25(12):4956-68 PMID: 15923614
  41. Skeletal muscle hypertrophy and atrophy signaling pathways.
    Int J Biochem Cell Biol. 2005 Oct;37(10):1974-84 PMID: 16087388
  42. MPromDb: an integrated resource for annotation and visualization of mammalian gene promoters and ChIP-chip experimental data.
    Nucleic Acids Res. 2006 Jan 1;34(Database issue):D98-103 PMID: 16381984
  43. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
    Oncogene. 2006 Feb 23;25(8):1125-42 PMID: 16314846
  44. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression.
    Mol Cell Biol. 2006 May;26(9):3565-81 PMID: 16611997
  45. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Clin Immunol. 2006 Sep;120(3):297-309 PMID: 16784892
  46. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.
    J Clin Invest. 2006 Nov;116(11):2945-54 PMID: 17080195
  47. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
    J Clin Invest. 2007 Apr;117(4):889-901 PMID: 17380205
  48. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK.
    Am J Physiol Cell Physiol. 2007 May;292(5):C1660-71 PMID: 17151142
  49. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
    Annu Rev Immunol. 2000;18:621-63 PMID: 10837071
  50. IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes.
    J Mol Cell Cardiol. 2000 Jul;32(7):1341-52 PMID: 10860774
  51. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
    Science. 2000 Sep 29;289(5488):2363-6 PMID: 11009425
  52. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
    J Clin Invest. 2001 Feb;107(3):241-6 PMID: 11160144
  53. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective.
    Respir Res. 2001;2(5):269-72 PMID: 11686894
  54. Regulatory functions of ubiquitination in the immune system.
    Nat Immunol. 2002 Jan;3(1):20-6 PMID: 11753406
  55. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.
    Mol Cell. 2002 Mar;9(3):587-600 PMID: 11931766
  56. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.
    Oncogene. 2002 May 23;21(23):3739-53 PMID: 12032842
  57. RIP2, a checkpoint in myogenic differentiation.
    Mol Cell Biol. 2002 Aug;22(16):5879-86 PMID: 12138198
  58. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products.
    J Biol Chem. 2003 Jan 24;278(4):2294-303 PMID: 12431991
  59. NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets.
    Curr Med Chem. 2003 Apr;10(7):593-602 PMID: 12678791
  60. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1.
    Genes Dev. 2003 Apr 15;17(8):1019-29 PMID: 12704081
  61. NF-kappaB and virus infection: who controls whom.
    EMBO J. 2003 Jun 2;22(11):2552-60 PMID: 12773372
  62. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k.
    FASEB J. 2003 Jun;17(9):1048-57 PMID: 12773487
  63. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.
    Genes Dev. 2003 Oct 1;17(19):2368-73 PMID: 14522944
  64. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
    J Immunol. 2004 Jan 15;172(2):1054-64 PMID: 14707079
  65. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
    FASEB J. 2004 Feb;18(2):227-37 PMID: 14769817
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2007-06-00
Epub
2007-00-16
Pages
4374-87
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC1900043
Subset
IM
Grants
NIAMS NIH HHS · F32 AR054244 · United States
NCI NIH HHS · K01 CA097953 · United States
NIAMS NIH HHS · AR054244 · United States
NCI NIH HHS · CA97953 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com